CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, June 17th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...